Our Clinical Advisors

Our Clinical Advisory Committee is comprised of a panel of nationally recognised experts within each cancer speciality. Our clinical advisors represent some of the UK’s most experienced cancer specialists, many of whom are recognised as key opinion leaders in their field.


Professor Richard Hindley, Clinical Advisor for Prostate Cancer

The evidence to support the use of routine PSA testing is stronger than ever. PSACheck enables men to have the test performed and provides all the necessary support and guidance should the test flag anything of concern. An early PSA test as a ‘marker in the sand’ is very useful and can be used for future comparison and improves hugely the utility of this simple and inexpensive test.

Find out more

Professor Gordon Wishart, Chief Medical Officer

With more than 30 years experience as a cancer surgeon, I set up Check4Cancer to ensure that our clients and patients had rapid access to innovative and validated cancer screening, cancer diagnostic and cancer genetic investigations and in doing so, Check4Cancer has become a trusted and reliable provider of these services to insured, corporate and self-funding sectors.

Find out more

Jullien Brady, Clinical Advisor for Cervical Cancer

HPVCheck allows women to take charge of their cervical screening choices. It removes almost all of the barriers to traditional screening, allowing women to perform the HPV triage test themselves with rapid and personalised risk assessment results.

Find out more

Professor Andrew Beggs, Clinical Advisor for Bowel Cancer & Genetics

If you have had a type of cancer that could be caused by a genetic predisposition, or if you have a strong family history of cancer, genetic testing may be useful for you and your family.  If a gene variant is identified, this may affect your treatment options and provide information, to allow you to manage any future cancer risks accordingly. If the results are normal, this would provide reassurance for you and your family.

Find out more

Professor Simon Russell, Deputy Chief Medical Officer

Diagnosing breast cancer early and then getting the best available treatment is vital in reducing the risk of dying from breast cancer. When found early, when small and before it has had a chance to spread, breast cancer is easier to treat successfully. Regular breast screening leads to cancers being discovered before they can be felt, when they are smaller and when they are less likely to have spread.

Triple assessment in a one-stop clinic with clinical examination, breast imaging and biopsy, ensures a rapid diagnosis, enabling prompt treatment and a better outcome as well as reducing anxiety and stress.

Find out more

Mr Per Hall, Clinical Advisor for Skin Cancer

It is important to check your moles and skin and come forward with any lesion on the skin which has either changed in size, shape or colour or is new. This advice helps to a degree but only by careful evaluation of the story of that changing mole supported by careful evaluation of detailed pictures which look at the structure of it within the skin (dermoscopy) can guidance be given. SkinCheck helps separate out lesions that have friendly appearances from those that need to be considered more carefully in case they are suspicious of skin cancer.

Find out more

Professor Sam Janes, Clinical Advisor for Lung Cancer

More men and more women die of lung cancer than any other cancer. Survival rates are currently low because it is detected late. The key for the future is to improve testing to allow early diagnosis of lung cancer and other cancers when they can be cured.

Find out more